Navigation Links
CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study
Date:7/22/2008

pipeline of selective cannabinoid compounds that have recently completed successful preclinical proof-of-concept studies for the treatment of pain, glaucoma and obesity. More information about CeNeRx BioPharma can be found at http://www.cenerx.com.

Contact:

GendeLLindheim BioCom Partners

Barbara Lindheim

212 918 4650


'/>"/>
SOURCE CeNeRx BioPharma
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. CeNeRx BioPharma Announces Successful Completion of Phase l Clinical Program for Novel Antidepressant Agent Tyrima(TM)
2. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
3. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
4. Nabi Biopharmaceuticals Announces Continued Positive NicVAX Phase 2b Data at Nine Months
5. Keryx Biopharmaceuticals to Present at William Blair & Company Small-Cap Growth Stock Conference
6. Morria Biopharmaceuticals Plc Initiates Phase I Clinical Study of MRX-4 in Allergic Rhinitis
7. Keryx Biopharmaceuticals, Inc. Announces Positive Preliminary Phase 2 Data on KRX-0401 in Patients with Chemo-Insensitive Rare Sarcoma
8. Nabi Biopharmaceuticals Announces Successful Completion of NicVAX(R) Phase 2b Trial; Drug Shows Statistically Significant Rates of Smoking Cessation and Continuous Long-Term Smoking Abstinence at 12 Months
9. Inspiration Biopharmaceuticals Announces Filing of IND for Novel Recombinant Factor IX Product, IB1001, for the Treatment of Hemophilia B
10. Immunosyn Announces Biozyme Labs Receipt of MHRA Manufacturing License Approval in Europe for the Biopharmaceutical SF-1019
11. Keryx Biopharmaceuticals, Inc. Announces Phase 1 and Phase 2 Data on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Multiple Myeloma at 49th Annual Meeting of American Society of Hematology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... researchers with EDP Biotech Corporation (EDP) have captured ... a simple blood test to detect early-stage colon ... its pre-clinical trials for the ColoMarker(TM) assay, EDP ... and all aspects of its use. Via ... cancer in its earliest, most curable stages. ,, ...
(Date:12/15/2009)... Tenn., Dec. 15 Cumberland Pharmaceuticals ... announced new top-line results for a patient ... Oral Solution, a prescription laxative packaged as a ... forms. ,, Kristalose is the only prescription-strength laxative ... period, 50 patients with a recent diagnosis of ...
(Date:12/15/2009)... Dec. 15 Today,s New ... "Plan for Kidney Drugs Spurs Division," illustrates an ... in kidney patients continuing to be deprived of ... Medicare program limit. ,, As Congress is poised ... preserve the lives of transplant kidney recipients, behind-the-scenes ...
Breaking Medicine Technology:Researchers Announce Medical Breakthrough with Simple, Inexpensive Blood Test for Colon Cancer 2Kristalose(R) Preferred by Patients With Chronic Constipation Compared to Similar Products in a Recent Study 2Kristalose(R) Preferred by Patients With Chronic Constipation Compared to Similar Products in a Recent Study 3AST Concerned That Kidney Transplant Patients May Suffer Politics As Usual in Capitol Hill Health Care Reform Debate 2Catalyst Pharmaceutical Partners Reports Third Quarter 2009 Financial Results 6197 1Catalyst Pharmaceutical Partners Reports Third Quarter 2009 Financial Results 6197 2Catalyst Pharmaceutical Partners Reports Third Quarter 2009 Financial Results 6197 3Catalyst Pharmaceutical Partners Reports Third Quarter 2009 Financial Results 6197 4Catalyst Pharmaceutical Partners Reports Third Quarter 2009 Financial Results 6197 5Catalyst Pharmaceutical Partners Reports Third Quarter 2009 Financial Results 6197 6Chimerix to Present at Two Upcoming Investor Conferences 6195 1Chimerix to Present at Two Upcoming Investor Conferences 6195 2Behavior modification could ease concerns about nanoparticles 10701 1Behavior modification could ease concerns about nanoparticles 10701 2
... and Specific Molecular Structures Needed for siRNA ... ... Silence Therapeutics plc,(AIM:SLN) Europe,s leading RNAi-focused biotechnology company, today,comments on ... via TLR3" Mark E.,Kleinman, et. al., and Molecules and Cells(2) ...
... Data from five studies sponsored,by Ortho Biotech ... Kidney,Foundation (NKF) 2008 Spring Clinical Meetings from April ... (Epoetin alfa)., The data include studies that ... and darbepoetin alfa (DARB), evaluate medical costs,related to ...
Other Medicine Technology:Recent siRNA Research Publications Support Silence Therapeutics Combined Development Approach 2Recent siRNA Research Publications Support Silence Therapeutics Combined Development Approach 3Recent siRNA Research Publications Support Silence Therapeutics Combined Development Approach 4Data From Ortho Biotech-Sponsored Studies to be Presented at National Kidney Foundation 2008 Spring Clinical Meetings 2Data From Ortho Biotech-Sponsored Studies to be Presented at National Kidney Foundation 2008 Spring Clinical Meetings 3Data From Ortho Biotech-Sponsored Studies to be Presented at National Kidney Foundation 2008 Spring Clinical Meetings 4Data From Ortho Biotech-Sponsored Studies to be Presented at National Kidney Foundation 2008 Spring Clinical Meetings 5Data From Ortho Biotech-Sponsored Studies to be Presented at National Kidney Foundation 2008 Spring Clinical Meetings 6
(Date:12/15/2009)... it,s still too early to say that ... TUESDAY, Dec. 15 (HealthDay News) -- Common chemicals ... to the abnormal growth of breasts in boys, ... in a prominent medical journal for pediatricians, adds ... phthalates, whose safety has been questioned by some ...
(Date:12/15/2009)... a leading provider of secure USB devices, today launches SafeConsole ... flash drive. The software is designed to provide better usability ... of new features and range of licensing options. , ... ... -- BlockMaster ( www.blockmastersecurity.com ) a leading provider of secure ...
(Date:12/15/2009)... goes up within a week of getting news, ... -- Emotional stress can put newly diagnosed prostate ... and suicide, a new study has found. , ... with prostate cancer between 1961 and 2004. Of ... event within a year of cancer diagnosis and ...
(Date:12/15/2009)... Accelify is proud to announce the addition of David ... serve as Director of Development in the State of ... Advisors. ,, David Tokofsky was elected to ... in June 1995. As the Board Member for District ... from Northeast Los Angeles through East Los Angeles to ...
(Date:12/15/2009)... Health Technologies, Inc. (OTC Bulletin Board: VHGI) confirmed ... subsidiary of VHGI) has appointed two key industry ... with bringing the Treasure Gulch and Zero Gold ... Additionally, the company is informing interested shareholders and ... Live Investor Town Hall Meeting so that investors ...
Breaking Medicine News(10 mins):Health News:Breast Growth in Boys Might Be Linked to Plastics Chemical 2Health News:Breast Growth in Boys Might Be Linked to Plastics Chemical 3Health News:BlockMaster Launches SafeConsole 4.0 To Enhance Usability and Security of USB Devices 2Health News:BlockMaster Launches SafeConsole 4.0 To Enhance Usability and Security of USB Devices 3Health News:Accelify Announces the Addition of David Tokofsky to its National Board of Advisors 2Health News:VHGI: VHGI Gold Taps Key Mining Professionals to Assist With Development Plan for $50,000,000 Potential Reserves at Treasure Gulch Gold Mine; Investor Town Hall Meeting to be Scheduled 2Health News:VHGI: VHGI Gold Taps Key Mining Professionals to Assist With Development Plan for $50,000,000 Potential Reserves at Treasure Gulch Gold Mine; Investor Town Hall Meeting to be Scheduled 3Health News:VHGI: VHGI Gold Taps Key Mining Professionals to Assist With Development Plan for $50,000,000 Potential Reserves at Treasure Gulch Gold Mine; Investor Town Hall Meeting to be Scheduled 4Health News:VHGI: VHGI Gold Taps Key Mining Professionals to Assist With Development Plan for $50,000,000 Potential Reserves at Treasure Gulch Gold Mine; Investor Town Hall Meeting to be Scheduled 5
... 25 Musketeer Group, Inc. and Coalition,America, Inc. ... unique,repricing solution for Musketeer customers. The partnership streamlines ... greater,administrative and medical claim savings. CAI,s integration with ... claims,as well as expedited adjudication of repriced claims. ...
... American Society,for Therapeutic Radiology and Oncology has published ... Gynecologic Cancers. The brochure,provides women coping with a ... radiation therapy and their treatment options, as well,as ... how to care for,themselves while undergoing treatment. ...
... Diego, September 25, 2007 Some people are caught ... own abuse as a child and continuing into perpetration ... it is important to understand how childhood experiences are ... published in the October issue of the American Journal ...
... in The Netherlands have developed a method of accurately ... to have their disease recur after surgery and who ... , Led by Professor Rob Tollenaar at Leiden University ... The Netherlands Cancer Institute, they have analysed for the ...
... Wash., Sept. 25 Cardiac Science,Corporation (Nasdaq: ... advanced cardiac monitoring,and defibrillation products, today applauded ... lay rescuers from the Pittsburgh school district ... (Logo: http://www.newscom.com/cgi-bin/prnh/20050913/SFTU139LOGO ) Cardiac ...
... Mass., Sept. 25 CutisPharma, Inc. has ... as its preferred,vendor for unit-of-use compounding kits. ... Shoppe(R) and Medicap Pharmacy(R) franchisees the ability ... pharmacies already providing the,service, to increase the ...
Other Medicine News:Health News:Coalition America Renews Relationship with Musketeer to Offer Streamlined Claims Repricing and Adjudication Solution for Benefit Administrators 2Health News:Updated Brochure on Gynecologic Cancer Treatments Now Available 2Health News:Victims of child maltreatment more likely to perpetrate youth violence, intimate partner violence 2Health News:Molecular profiling can accurately predict survival in colon cancer patients 2Health News:Molecular profiling can accurately predict survival in colon cancer patients 3Health News:Cardiac Science Applauds Mass AED Training of Pittsburgh Educators 2Health News:Cardiac Science Applauds Mass AED Training of Pittsburgh Educators 3Health News:Cardiac Science Applauds Mass AED Training of Pittsburgh Educators 4Health News:CutisPharma Selected by Medicine Shoppe International as Preferred Vendor for Unit-of-Use Compounding Kits 2Health News:CutisPharma Selected by Medicine Shoppe International as Preferred Vendor for Unit-of-Use Compounding Kits 3
Fluoro done? Get rid of your apron quickly and easily without breaking the sterile field. A shoulder drop-away can also be used with our Stretchy-back and cummmberbund aprons. Shoulder pads and hangi...
Open armhole design with Velcro release enables removal without compromising sterile field. Loops attached at shoulders for proper hanging & storage...
This apron provides full protection all the way around. Extra wide Velcro strips provide many adjustments and a secure fit....
Unique criss-cross strapping distributes weight evenly over the torso for ultimate comfort and flexibility. Fully adjustable 2 inch belt and buckle for easy front closure....
Medicine Products: